Sonoma Pharmaceuticals (SNOA) Cash from Operations (2010 - 2025)

Sonoma Pharmaceuticals' Cash from Operations history runs 16 years deep, the most recent figure standing at 764000.0 for Q4 2025.

• In Q4 2025, Cash from Operations fell 235.22% year-over-year to 764000.0; the TTM figure through Dec 2025 stood at 3509000.0 (down 2306.92% YoY), while the FY2025 annual figure was 88000.0, up 96.33% from the prior year.
• Cash from Operations was 764000.0 for Q4 2025 at Sonoma Pharmaceuticals, down from 635000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 565000.0 in Q4 2024 to a low of 2441000.0 in Q1 2023.
• Historically, Cash from Operations has averaged 888800.0 across 5 years, with a median of 1008000.0 in 2023.
• Biggest YoY gain for Cash from Operations was 151.18% in 2024; the steepest drop was 324.19% in 2024.
• A 5-year view of Cash from Operations shows it stood at 326000.0 in 2021, then fell by 6.75% to 348000.0 in 2022, then tumbled by 217.24% to 1104000.0 in 2023, then soared by 151.18% to 565000.0 in 2024, then tumbled by 235.22% to 764000.0 in 2025.
• The last three Cash from Operations figures came in at 764000.0 (Q4 2025), 635000.0 (Q3 2025), and 2015000.0 (Q2 2025), per Business Quant data.